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In Nigeria, Community Pharmacists (CPs) and 
Patent and Proprietary Medicine Vendors 
(PPMVs) are the first point of care for many 
common illnesses within the community. 
Although CPs and PPMVs are not formally 
recognized as family planning (FP) service 
providers, 22% of modern contraceptive 
users report receiving their last method from 
a PPMV and 12% from a private pharmacy 
[1]. PPMVs are especially popular for FP due 
to their widespread availability, consistent 
drug stocks, extended hours, personable 
interactions, and no separate fees for 
consultations [2, 3]. As the Federal Ministry 
of Health (FMoH) explores expanding its task 
sharing policy to include CPs and PPMVs, 
evidence is needed on an effective 
regulatory system to support PPMVs and CPs 
to provide high quality FP services. 
THE INTEGRATE PROJECT 
The IntegratE Project is a four-year initiative 
(2017-2021) funded by the Bill & Melinda 
Gates Foundation and MSD for Mothers1 
 
1 This program is co-funded by, developed and is being 
implemented in collaboration with MSD for Mothers, MSD’s $500 
million initiative to help create a world where no woman dies 
giving life. MSD for Mothers is an initiative of Merck & Co., Inc., 
Kenilworth, NJ, U.S.A   
 
that seeks to increase access to 
contraceptive methods by involving the 
private sector (CPs and PPMVs) in FP service 
delivery in Lagos and Kaduna states. 
IntegratE is implemented by a consortium of 
partners led by Society for Family Health and 
include others like Marie Stopes 
International Organization Nigeria, Planned 
Parenthood Federation of Nigeria, 
Population Council and PharmAccess. The 
project seeks to establish a regulatory 
system with the Pharmacists Council of 
Nigeria (PCN) to ensure that CPs and PPMVs 
provide quality FP services, comply with FP 
regulations, and report service statistics to 
the Health Management Information System 
(HMIS). To achieve this, the IntegratE Project 
in collaboration with PCN and the FMoH, is 
implementing three main activities: (1) a 
pilot 3-tiered accreditation system for 
PPMVs based on their healthcare 
qualifications; (2) a pilot hub-and-spoke 
supervisory model where CPs (the hub) 
provide support to PPMVs (spokes) to 
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ensure standard drug stocking practices; and 
(3) building the capacity of CPs and PPMVs 
to provide expanded FP services and report 
service statistics to the HMIS. Under the pilot 
accreditation system, PPMVs were provided 
with a standardized FP training to enable 
them to offer certain FP services based on 
their tier (Table 1). CPs function outside of 
the pilot accreditation system but would 
receive the same training and provide the 
same services as Tier 2 PPMVs. The IntegratE 
Project is simultaneously raising awareness 
about the FP services that CPs and PPMVs 
provide. This brief focuses on quality of care 
received by women voluntarily seeking FP 
services from CPs and PPMVs. Additional 
information on IntegratE Project can be 
found on www.integrateeproject.org.ng. 
 
METHODS 
The IntegratE project conducted qualitative 
in-depth interviews with 11 CPs, 17 PPMVs 
and 31 clients of these providers in July 
2019. Participants were selected through 
purposive sampling in Kaduna and Lagos 
states. Interviews were conducted by 
trained research assistants using semi-
structured guides that assessed the 
supervisory structure of CPs and PPMVs, and 
their expectations of the PCN accreditation 
system. Clients who patronized these 
providers for FP were asked about their 
perception of the care they had received, 
their interaction with the provider, their 
satisfaction with the method they obtained, 
and the support of their partner for their 
choice to use modern contraception.  
 
Themes were identified manually and 
findings synthesized in the present brief. The 
key themes addressed in this brief include: 
(1) Clients’ perception of and satisfaction 
with quality of FP services received; (2) 
Providers’ perception of quality of FP 
services rendered; (3) Supportive 
supervision is key for delivering quality FP 
services; (4) Streamlining drug stock 
practices; (5) Ensuring an enabling 





Table 1: Description of tier accreditation system  
Provider 
type 







• FP counseling and 
referral 







Same as tier 1 and; 
• Provide oral 












Same as tier 1 and;  
• Provide oral 




• Implant insertion and 
removal 
CPs Outside of 
accreditation 
system 
Same as tier 1 and; 
• Provide oral 











Clients’ perception of and satisfaction with 
the quality of FP services received 
 
Clients’ perception of the quality of FP 
services that they received included sub-
themes related to the setting of the care, the 
process of care, and the outcome of care. 
Regarding the setting, clients were generally 
comfortable with the location of, and the 
ease of access to the community pharmacy 
or PPMV shop. Women reported that they 
perceived the setting to be private, but clear 
distinctions between visual and auditory 
privacy were not made. Women chose to 
visit these providers based on previous 
positive interactions, knowledge of the CP or 
PPMV’s health training background, referral 
from other clients who were well known to 
them, referral from friends, proximity to 
their home, and short waiting time for 
services. Some female clients contrasted 
their experience with the CP or PPMV to 
previous experiences in a public health 
facility, particularly with regard to the 
provider’s reception and the waiting time. 
Some of their experiences are exemplified 
by the following quotes:  
 
“I went there [the health facility], the 
queue, I couldn’t wait because of the 
queue, and the customers were 
waiting for me in the shop, so I have to 
come back and look for plan B, which I 
went to [the] chemist, she attends to 
me very well.”  
-- Client using 2-monthly injectable; 
Kaduna state 
 
“… when you go the general hospital, 
they delay a lot; you will queue, wait 
to collect [a] card before you are 
attended to, but the chemist here, I 
use my money to collect it [the 
injectable] and I am satisfied with it. 
Anytime I get there, there is no delay, 
I don't have to queue, that's the 
reason.” 
-- Client using 3-monthly injectable; 
Lagos state 
 
Clients described interactions with the CP or 
PPMV they visited in glowing terms, using 
expressions like ‘motherly’, ‘friendly’, 
‘warm’, ‘caring’, ‘patient’, and ‘respectful’. 
Several women expressed that their 
relationship had grown beyond that of a 
client and provider to that of a friend and 
confidante and noted that the provider 
would often call them to check on their 
welfare after their visit. Some women 
sought health care for other members of 
their family from the PPMV who provided 
them their FP services. One female client 
described her relationship with her provider 
in the following way: 
 
“To be honest, even apart from the FP, 
all my children, if they are sick, it’s 
there [PPMV shop] that I normally 
collect my treatment, even though I 
don’t have money, she will treat them, 
any day I have money, I will take it to 
her.” 
-- Client using 2-monthly injectable; 
Kaduna state 
 
Women recalled discussing potential side 
effects, what to do if they experienced side 
effects, and when to return to the CPs and 
PPMVs. Some women felt confident to 
continue their chosen method (injectable, 
implant) because they had been informed of 
the potential for side effects such as 
amenorrhea and bleeding. Many were also 
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informed that they could switch methods if 
the side effects experienced were 
bothersome. Additionally, most women on 
implants recalled being told they should 
return to any provider with training and skills 
in implant removal whenever they were 
ready to remove the implant.  
 
Women expressed their satisfaction with the 
FP services received by saying they were 
‘very satisfied’, ‘satisfied’, or ‘happy’ with 
the way they were treated, and with their 
experience with the PPMV. One female 
client said,  
“I can recommend anyone to her. 
Because I truly enjoy her services.”  
-- Client using 2-monthly injectable; 
Kaduna state 
 
Partner Engagement in Family Planning 
Clients often referred to the PPMV’s efforts 
to ensure that their husband/partner was at 
least aware of her decision to use FP, even if 
he was not willing to come with her to the 
PPMV shop. Some women commented that 
the CP or PPMV requested to talk to them 
together, as a couple. Many women 
reported that their male partners’ 
involvement in their use of FP took different 
forms: by encouraging them to use a 
method, accompanying them to the PPMV 
shop or pharmacy, and paying for related 
expenses. A few women noted that their 
partners were not involved in their decision 
to use a FP method. Reasons given ranged 
from being a single mother who chose not to 
discuss her FP use with her current partner, 
to a woman choosing to use covertly due to 
her partner’s lack of support for her choice. 
 
CPs and PPMVs 
Providers’ perception of quality of services 
rendered to clients 
 
Both CPs and PPMVs felt the care they 
offered clients was good, as evidenced by 
return visits, recommendations by previous 
clients, and appreciation by both clients and 
male partners who sometimes accompanied 
their wives. CPs and PPMVs appreciated the 
relevance of the FP training they received to 
their business, but some of the CPs regretted 
not yet being trained on the insertion and 
removal of implants, a method requested by 
some of their clients. Some of these CPs 
stated that they had schedule conflicts on 
the day of the training and were not aware 
of opportunities to attend other trainings on 
implant insertion and removal. CPs noted 
that they referred women because they 
lacked skills to administer a women’s desired 
method (e.g. implant) or did not have the 
requested FP commodity or medicine. CPs 
noted that they chose which primary health 
care facilities and/or other pharmacists to 
refer to, based on their knowledge of the 
professional competence of the provider, 
and feedback received from previous clients 
who were referred to various places. PPMVs 
on the other hand generally preferred to 
refer to nearby government health facilities, 
and even when asked directly, most stated 
or implied their reluctance to refer clients to 
other PPMVs and CPs near them, as they 
were afraid they would lose these clients. 
For both CPs and PPMVs, reasons for referral 
were generally to obtain a drug or FP 
commodity they did not have in stock, or a 
service they did not have the skill or 
equipment to offer. 
 
Supportive supervision is key for delivering 
quality FP services 
 
For the most part, the relationship between 
CPs and PPMVs was not cordial. Both parties 
saw the other as rivals who were out to 
capture clientele that should rightly be 
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theirs. Several CPs felt there was no 
justification to have PPMVs in urban areas 
where there were enough pharmacists. 
These CPs felt that PPMVs were meant to be 
a stopgap to provide services in rural and 
hard-to-reach areas, not to compete with 
pharmacists in urban areas. Some CPs felt 
that the biggest challenge of training PPMVs 
was that they had the tendency to overstep 
boundaries and offer services that were not 
within their legal scope of practice. Even 
some PPMVs stated that they knew that 
their colleagues had the tendency to stock 
drugs they were not licensed to stock and 
offered services that were not in their 
purview. Some CPs suggested that they were 
aware of PPMVs who had been caught 
selling narcotics and other drugs. In 
frustration, when referring to PPMVs, a male 
CP said, “…they are becoming a menace”. 
One CP reported that PPMVs were a threat 
to CPs because they could arrange for the 
pharmacy of a CP to be robbed if they felt the 
presence of the CP in the community was 
not allowing their own business to flourish.  
 
Despite these perceptions of PPMVs, CPs 
generally felt the supportive supervisory 
system2 could work, but that there would 
need to be efforts toward building trust, and 
helping each group see that the relationship 
could be mutually beneficial. While some 
PPMVs said they have a good relationship 
with CPs, and had a lot to learn from them, 
most appeared to be of the opinion that they 
had to make peace with the CPs practicing 
near them to guarantee the survival of their 
own business. Some PPMVs appeared to 
think CPs had a chip on their shoulder. One 
PPMV was very clear about what she 
thought: 
 
2 The supportive supervisory system refers to the system whereby 
a pharmacist supports or supervises a group of PPMVs on 
pharmaceutical care and drug management. This system is also 
“…there is no relationship. They even 
see us like an enemy. They feel that 
we are not professional…” 
 
“They [CPs] feel they should be the 
alpha and omega, they should be the 
only one selling [drugs], and that is 
the same problem they have with the 
nurse. They will say nurses are not 
supposed to sell drugs, even they are 
not supposed to treat.” 
--PPMV; Lagos state 
 
Streamlining drug stock practices 
 
While most CPs reported that they 
documented drug purchases, sales and 
stocks using ledgers, which assisted in 
decision making regarding when and what to 
restock, PPMVs were less likely to report 
such an organized system. Apart from 
demand, other considerations in drug 
stocking reported by both CPs and PPMVs 
included shelf life (“first in, first out” 
approach) and season, with anti-allergens 
being in great demand during the rainy 
season. Some PPMVs also noted that they 
took the purchasing power of their clients 
into consideration when deciding which 
drugs to buy. CPs generally bought their 
drugs from companies, medical drug 
representatives, distributors, and the open 
market while PPMVs mostly bought from 
pharmacies, medical drug representatives, 
and the open market. 
 
Some CPs noted that they avoided stocking 
drugs that require refrigeration due to poor 
electricity supply. The National Agency for 
Food and Drug Agency was said to be 
concerned with ensuring CPs and PPMVs did 
referred to as the hub-and-spoke supervision model where the CP 
is the ‘hub’, supervising several PPMVs, the ‘spokes’. 
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not stock unlicensed or expired drugs and 
did this through unscheduled visits to 
pharmacies or shops. However, one CP 
reported that they sometimes harassed CPs. 
He described how they once showed up with 
guns to his pharmacy and he had to calm his 
staff down, explaining that he had done 
nothing wrong. 
 
Ensuring an enabling environment 
 
CPs complete an annual online license 
renewal form after their initial registration 
with PCN. Both CPs and PPMVs reported that 
after submitting an initial application in 
writing, PCN inspects their proposed 
premises to assess the suitability of the 
location for a pharmacy or patent medicine 
shop, using preset criteria. PCN makes both 
scheduled (every 2 years) and unscheduled 
monitoring visits. However, while most CPs 
and PPMVs felt PCN was effective in their 
work, a few expressed concerns that PCN 
under-performed due to delays in location 
inspection, inadequate manpower, an 
insufficient number of vehicles, and 
inadequate funds. This implied that PCN’s 
mandatory site inspection prior to licensing 
a new pharmacy or patent medicine shop 
was sometimes not done, thus allowing 
pharmacies or patent medicine stores to be 
too close to each other (less than 200 m), 
which is against extant regulations [4]. 
Furthermore, CPs and PPMVs reported that 
PCN organized training and re-training 
exercises for CPs and PPMVs, though these 
did not occur as regularly as expected.  
 
The National Drug Law Enforcement Agency 
was reported by both CPs and PPMVs to 
make only targeted visits, possibly related to 
information they obtained regarding who 
was selling medicines they were not licensed 
to sell. In general, CPs and PPMVs felt that 
these regulatory bodies were important for 
ensuring and improving quality and that they 
made most providers to work hard to stay 
within the ambit of the law. Some CPs 
complained that regulatory bodies were 
“over-regulating” whereby they would make 
repeated visits to some pharmacies within 
the same year, but not visit others 
(registered or unregistered) for years – 
possibly due to the ease of access or 
proximity to their office. One CP summarized 
his expectations of the regulatory bodies 
thus: 
 
“So, that enabling environment, the 
regulators must be able to understand 
that it behooves them to create an 
enabling environment for every 
practitioner in the system, first and 
foremost to practice ethically.”  
--Community Pharmacist; Lagos state 
 
Pharmacists Council of Nigeria’s proposed 
accreditation system 
 
While one CP did not know about PCN’s 
proposed accreditation system, others had 
varying degrees of understanding. On the 
other hand, most PPMVs had not heard 
about the proposed accreditation system. 
Everyone expressed their acceptance in one 
way or the other, even if they were hearing 
about the accreditation system for the first 
time, and even if they had concerns. Most 
said the development was a “good thing” 
but were curious as to what the roll out 
would look like. Most CPs expressed serious 
concerns about whether PPMVs would 
remain within their legal scope of practice. 
However, they were willing to work with 
them under the right supervisory 
environment, as they appreciated the gap 
that PPMVs filled by providing services 




IMPLICATIONS OF FINDINGS 
The implications of these findings are that 
since CPs and PPMVs and their clients 
appear to be satisfied with the FP services 
offered by CPs and PPMVs, on-going learning 
opportunities, and a supportive supervision 
system that is properly coordinated should 
be sufficient to maintain the quality of 
services offered by CPs and PPMVs. The 
existing tension between CPs and PPMVs 
suggests the need for their respective 
professional bodies to work together to 
build trust and an amicable relationship 
between their members. PCN, as well as the 
professional national and local associations 
for CPs and PPMVs are responsible for 
ensuring the right enabling environment for 
these cadres of health workers to perform 
optimally. However, shortcomings of PCN as 
a regulatory body were identified, and these 
need to be addressed directly. The proposed 
accreditation system appears to be 
workable, provided the concerns and 




Nigeria’s low modern contraceptive 
prevalence must be addressed. One  
approach that has been shown to work is the 
shifting and sharing of tasks with other 
cadres of health workers who have not 
traditionally been part of Nigeria’s FP service 
delivery program. CPs and PPMVs are 
already an important source of care for 
women and men in the communities they 
serve. When properly trained and 
supervised, these cadres of providers can 
help to improve access to FP information 
and services, and thus help to increase 
demand for, and use of FP methods.  
Engaging multiple cadres of providers 
through training and supportive supervision 
will help to expand access and choice so that 
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